Lowy and Schiller

Doug Lowy and John Schiller receive the Szent-Györgyi Prize for Progress in Cancer Research

Posted: Feb 15, 2018

The National Foundation for Cancer Research (NFCR) will honor CCR’s Doug Lowy, M.D., Chief of the Laboratory of Cellular Oncology, and John Schiller, Ph.D., Deputy Chief of the Laboratory of Cellular Oncology, with the Szent-Györgyi Prize for Progress in Cancer Research during a ceremony on May 5 in Washington, D.C. The annual prize, named after NFCR’s co-founder, Albert Szent-Györgyi, M.D., Ph.D., honors scientists who have made an original discovery or breakthrough in scientific understanding that has had a lasting impact on the cancer field and saving people’s lives. In addition to the more than 150 papers co-authored by Drs. Lowy and Schiller, the duo’s research has led to great advances in understanding HPV infection and the development of three preventive HPV vaccines approved by the U.S. Food and Drug Administration. Read more…

Doug Lowy and John Schiller receive the Szent-Györgyi Prize for Progress in Cancer Research
ASCO logo

CCR scientists help develop first recommendations for managing mesothelioma

Posted: Feb 7, 2018

Anish Thomas, M.B.B.S., M.D., Investigator in the Developmental Therapeutics Branch, Markku Martti Miettinen, M.D., Ph.D., Senior Clinician in the Laboratory of Pathology, and Raffit Hassan, M.D., Co-Chief of the Thoracic and Gastrointestinal Oncology Branch, are among the contributing authors of the American Society of Clinical Oncology’s first guidelines for evidence-based recommendations on the management of mesothelioma. The guidelines were informed by 222 relevant studies. The recommendations were developed for diagnosis, staging, chemotherapy, surgical cytoreduction, radiation therapy and multimodality therapy in patients with mesothelioma. Learn more…

CCR scientists help develop first recommendations for managing mesothelioma
Kenneth Aldape, M.D.

Ken Aldape joins CCR as Chief, Laboratory of Pathology

Posted: Feb 5, 2018

Kenneth Aldape, M.D., has joined CCR as the Chief of the Laboratory of Pathology. Dr. Aldape’s research interests focus on the molecular pathogenesis and classification of brain tumors, particularly malignant gliomas and meningliomas. His passion is to apply new molecular technologies to classify tumors from a biological perspective. Learn more...

Ken Aldape joins CCR as Chief, Laboratory of Pathology
Dr. Yves Pommier

Yves Pommier named fellow of the American Association for the Advancement of Science

Posted: Jan 23, 2018

Yves Pommier, M.D., Ph.D., Chief of the Developmental Therapeutics Branch, was recently elected a fellow of the American Association for the Advancement of Science (AAAS). Election as a fellow honors AAAS members whose efforts to advance science or its applications have distinguished them among their peers and colleagues. The 2017 AAAS Fellows will be recognized on Feb. 17, 2018 at the AAAS annual meeting in Austin, TX. Read more...

Yves Pommier named fellow of the American Association for the Advancement of Science
Dr. Michael Gottesman

Michael Gottesman honored with Order of the Rising Sun by Japanese Government

Posted: Jan 19, 2018

The Government of Japan recently honored Michael Gottesman, M.D., Chief of the Laboratory of Cell Biology, with the Order of the Rising Sun, Gold Rays and Neck Ribbon, for his contributions toward promoting research exchange in the biomedical field between the U.S. and Japan. The Order of the Rising Sun was established in 1875 as the first national decoration awarded by the Japanese government. Read more...

Michael Gottesman honored with Order of the Rising Sun by Japanese Government
Natalie Porat-Shliom, Ph.D.

Natalie Porat-Shliom joins CCR as NIH Stadtman Investigator

Posted: Jan 8, 2018

Natalie Porat-Shliom, Ph.D. has joined the Thoracic and Gastrointestinal Oncology Branch (TGIB) as a Stadtman Tenure Track Investigator. Dr. Porat-Shliom's research focuses on utilizing intravital microscopy for imaging and understanding the biology of human cancer. She will explore how normal and malignant cells metabolically adapt to changes in nutrient supply and energy demand and will address specific questions concerning metabolic heterogeneity under physiological conditions and metastatic disease using both mouse model and human samples. Learn more...

Natalie Porat-Shliom joins CCR as NIH Stadtman Investigator
Waldmann

Thomas Waldmann named Fellow of the National Academy of Inventors

Posted: Dec 13, 2017

Thomas A. Waldmann, M.D., Co-chief of the Lymphoid Malignancies Branch, has been named a Fellow of the National Academy of Inventors (NAI). According to the NAI, election to NAI fellow status is the highest professional accolade for academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and welfare of society. With the election of the 2017 class there are now 912 NAI Fellows, representing over 250 research universities and governmental and non-profit research institutes. On April 5, 2018, the 2017 NAI Fellows will be inducted as part of the Seventh Annual NAI Conference.  

Thomas Waldmann named Fellow of the National Academy of Inventors
Anupama Khare, Ph.D.

Anupama Khare joins CCR as NIH Stadtman Investigator

Posted: Dec 12, 2017

Anupama Khare, Ph.D. has joined the Laboratory of Molecular Biology as a Stadtman Tenure Track Investigator. Dr. Khare's research focuses on understanding how different microbial species co-exist in the same environmental niche and what the molecular interactions in such communities are. She is also interested in studying antibiotic persistence and identifying novel bacterial pathways that can be targeted for antimicrobial therapy in investigating the genetic basis of complex bacterial behaviors in natural environments, with an overarching goal of identifying novel targets for antibiotic therapies. Learn more...

Anupama Khare joins CCR as NIH Stadtman Investigator
Dr. Claudia Palena

Claudia Palena appointed as tenured senior investigator

Posted: Nov 27, 2017

Claudia Palena, Ph.D., has been appointed as a tenured senior investigator in the Laboratory of Tumor Immunology and Biology (LTIB). Dr. Palena’s laboratory focuses on the immunological targeting of drivers of tumor dissemination and resistance to therapy. Her recent work identified the novel tumor antigen brachyury as a key factor in epithelial to mesenchymal transition (EMT), a process associated with cancer progression. More recently, Dr. Palena’s efforts have been aimed at investigating immunotherapeutic approaches that may be used alone or in combination with anti-neoplastic agents to disrupt tumor metastasis and resistance to therapy.

Claudia Palena appointed as tenured senior investigator
Dr. Stephanie Goff

Stephanie Goff receives American College of Surgeons Fellowship

Posted: Nov 27, 2017

Stephanie Goff, M.D., Staff Clinician in the Surgery Branch, was among 1,827 initiates from around the world who became Fellows of the American College of Surgeons (FACS) during the convocation ceremony at the college’s annual Clinical Congress on Oct. 22, 2017. According to the college, Fellows have earned the distinguished right to use the designation of “FACS” (Fellow, American College of Surgeons) after their names. Fellowship requirements include completion of advanced training in one of 14 surgical specialties, certification by an American surgical specialty board or appropriate certification by the Royal College of Physicians and Surgeons of Canada and demonstrating ethical fitness and professional proficiency. The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and to improve the quality of care for the surgical patient.  

Stephanie Goff receives American College of Surgeons Fellowship

Pages